▶주메뉴 바로가기

▶본문 바로가기

검색폼

THE INVESTOR

Bio & Medicine

Korea bans import of GlaxoSmithKline’s nicotine gum

  • PUBLISHED :January 05, 2017 - 17:06
  • UPDATED :January 05, 2017 - 17:06
  • 폰트작게
  • 폰트크게
  • facebook
  • twitter
  • sms
  • print
[THE INVESTOR] South Korea’s state drug safety watchdog said on Jan. 5 it has imposed a temporary ban on imports of a smoking cessation gum produced by GlaxoSmithKline for a month on charges of violating the Pharmaceutical Affairs Act.

Starting from Jan 10, GlaxoSmithKline Consumer Healthcare Korea will be banned from importing Nicotin-L Gum 2mg as the company failed to report the changes of the nicotine replacement’s manufacturer, according to the Ministry of Food and Drug Safety.

By Park Han-na (hnpark@heraldcorp.com)
  • facebook
  • twitter
  • sms
  • print

EDITOR'S PICKS